PharmCAT.NET

Biostatistics, pharmacokinetics and clinical trials.

  • Home page
  • Blog
  • Contacts
  • Agreement & Confidentiality

IBM SPSS Extension: R Project PowerTOST library

Posted on December 31, 2018December 31, 2018 by frozencat

IBM SPSS Extension PowerTOST R Project library. Syntax command: POWERTOST.

Version: 1.0.0

Functions:

  • power.TOST
  • sampleN.TOST
  • CVfromCI

Дизайны:

  • parallel
  • 2×2
  • 2x2x4

Скачать/Download

GitHUB: https://github.com/PharmCat/SPSSPowerTOST

Categories: Blog, SPSS

Post navigation

Next Post:

Recent Posts

  • IBM SPSS + R Project: Confidence intervals for proportions, independent groups
  • IBM SPSS Extension: R Project PowerTOST library

Галерея

20180816 150746
DJI 0072
20170729 203919
20180815 152016
IMG-20170806-WA0036
20180814 160711
  • Drug Trials Snapshots
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Drug Trials Snapshot: VANRAFIA
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Patient Engagement Collaborative
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Biosimilar Product Information
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • FDA and Kratom
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-07-15
  • European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-07-15
  • European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-07-15
  • Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-15
  • Blood Guidances
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-07-15 By FDA
  • Patent Certifications and Suitability Petitions
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Recommendations for Testing Blood Donations for Hepatitis B Surface Antigen
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-07-15 By FDA
  • Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Date of authorisation: 25/04/2025, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-15
  • Hydroxie, LLC - 709661 - 06/25/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Royal Diamond Imports, Inc. - 709540 - 06/25/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
Older posts
Theme: Scaffold by Danny Cooper.